Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
OFD1 pseudogene 17 (OFD1P17) is a member of the OFD1 pseudogene family. Pseudogenes are DNA sequences similar to genes but typically nonfunctional; they do not produce active proteins and have lost their protein-coding potential. OFD1P17 is named for its similarity to the OFD1 gene, which is responsible for encoding a protein involved in cilia formation and human development. While the canonical OFD1 gene is linked to disorders such as oral-facial-digital syndrome type I, OFD1 pseudogenes like OFD1P17 do not have established biological activity, disease relevance, or therapeutic targeting roles[7].\n\nKey clarifications:\n- There is a risk of confusion with the canonical OFD1 gene, which is a disease-associated protein-coding gene implicated in developmental syndromes[1][3][7][8].\n- OFD1P17 is explicitly classified as a pseudogene, meaning it is not expected to be a receptor, enzyme, transporter, or any other druggable molecular target[7].\n- There are no known drugs, mechanisms of action, biomarker roles, or safety concerns associated specifically with OFD1P17[7].\n- Aliases listed overlap with other OFD1 family members or pseudogenes—appropriate caution should be taken in data mapping.\n\nThis entry should not be considered a valid molecular target for therapeutic intervention or biomarker use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on OFD1 pseudogene 17 (OFD1P17).